Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Aumolertinib effectively controls lung cancer and improves quality of life.

Alopecia areata greatly affects quality of life, with many experiencing mental health issues and lacking professional support.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.

Alopecia areata affects quality of life more in adolescents than adults.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Stressful life events may trigger alopecia areata.

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

A new treatment plan for alopecia areata considers disease severity, quality of life, and progression to offer personalized care.

Early diagnosis and management of Sheehan's syndrome are crucial for improving quality of life and fertility.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Dermatological diseases affect women's work performance more than men's.

The UK's EDS National Diagnostic Service found that early diagnosis, lifestyle advice, and regular check-ups are crucial for managing vascular Ehlers-Danlos syndrome. A combination of losartan and bisoprolol can reduce vascular events, improving survival and quality of life.

Older women reported negative physical and psychological effects from Botox and facial fillers, feeling neglected by the medical system.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.